Cyted Health is a pioneering gastrointestinal health company focused on transforming access to esophageal care through innovative, minimally invasive diagnostics. Their flagship product, the EndoSign test, utilizes a swallowable device combined with advanced laboratory biomarkers to detect esophageal cancer and its precursor, Barrett’s esophagus. Operating in the US and UK, Cyted Health is committed to expanding its pipeline to tackle significant challenges in gastroenterology and related fields. The company fosters a collaborative and inclusive culture, valuing diverse perspectives and empowering employees across various departments to lead projects and influence strategy. With a strong emphasis on patient impact and operational excellence, Cyted Health is dedicated to delivering reliable healthcare solutions and building lasting partnerships with NHS trusts.